Bioequivalence of domperidone tablets in Chinese healthy volunteers after a single oral administration

Dong CHAI,Yi FANG,Fei PEI,Bei-bei LIANG,Rui WANG
DOI: https://doi.org/10.3969/j.issn.1001-6821.2005.03.008
2005-01-01
Abstract:Objective To study pharmacokinetics and bioequivalence of domperidone maleic acid and motilium tablets in 20 Chinese healthy male volunteers. Methods A cross-over bioequivalence trial was designed and reviewed by independent ethic committee. Twenty Chinese healthy male volunteers were divided randomly into two groups. Each group was orally given domperidone maleic acid and motilium 10 mg.The plasma concentrations were determined by HPLC. Pharmacokinetic parameters and compartment model were obtained using 3P97.The bioequivalence test were studied on lnAUC (0-t), lnC (max) and t (max) by two one-side t test. Results HPLC me- thod for domperidone was sensitive, assured and accurate .After a single (oral dose) (10 mg), t (max) were (0.73±0.23)h and (0.73±0.24)h,C (max) were(18.78±4.50)μg·L~(-1) and (19.69±6.97)μg·L~(-1), AUC (0-t) were (74.84±19.61)μg·h·L~(-1) and (78.74±22.14)μg·h·L~(-1).The concentration-time curve is fitted with two-compartments model. The (relative) bioavailability was 95.54%.Conclusion Domperidone maleic acid and motilium are bioequivalent.
What problem does this paper attempt to address?